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Various endocrine glands have been implicated
as being important or essential for human Se-
haceous gland development. Major emphasis
has been directed toward the testis, the ovary,
the pituitary and adrenal glands. While con-
siderable information has been obtained from
the study of the effect upon the sebaceous gland
of the exogenous administration of specific
hormones, there remains a lack of precise knowl-
edge concerning their in vivo physiologic role.
An approach which could shed considerable
light on this problem is the study of sebaceous
glands following extirpation of endocrine secreting
organs. However, certain limitations to this type
of study are apparent with respect to glands such
as the ovary, the pituitary and the adrenal, all of
which are complex glands productive of more
than one hormone. Since the testis secretes
essentially only one type of hormone, namely
androgen, orchiectomized patients can serve as a
suitable experimental model for such a study.
Therefore, in this paper we are reporting the
results of an investigation of sebum production
and urinary steroid excretion in a large group of
surgically castrated males.
METHODS
Eighty-five institutionalized, mentally de-
fective castrate males, ranging in age from 30 to
78 years, were studied.t The majority of the
patients had undergone orchiectomy between the
age of 15 and 20 years, and most of the remainder
between 20 and 30 years. Only six patients had
been castrated before the age of 12. The duration
since castration varied from 10 to 26 years.
Physical examination did not disclose any gross
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endocrinologic defects except for those expected
after castration, namely sparseness of body hair
and a tendency toward female distribution of
pubic hair and gynecomastia.
Sebum production was determined by a method
described in detail elsewhere (1). In brief, after
suitable preparation of the forehead collection
site, the lipid delivered to a measured, delineated
area of the skin surface in a three-hour period was
collected on ether-washed cigarette papers, held
in place by a rubber bandage encircling the fore-
head. The lipid was then appropriately extracted
from the papers and assayed by gravimetric
technics. Sebum production studies were per-
formed on all subjects with a minimum of three
separate lipid collections obtained from each
subject. These values were compared to those
obtained in studies of intact males and females of
similar ages.
In fourteen castrate subjects, 32 to 49 years of
age, analyses of the 24-hour urine excretion of
individual 17-ketosteroids and of total 17-
hydroxycorticoids were performed. These urine
specimens were collected under strict observation
and supervision in a hospital ward to insure a
complete 24-hour specimen. The adequacy of the
collection was confirmed by measuring the 24-
hour excretion of creatinine in each sample.
Similar steroid analyses of 24-hour urine samples
from seven normal intact males, 35 to 45 years
old, served as controls.
The method for the analysis of the 17-ketos-
teroids consisted of enzymatic hydrolysis of the
17-ketosteroid conjugates with Glusulase® (con-
taining glucuronidases and sulfatases) and separa-
tion into individual component 17-ketosteroids by
paper partition chromatography in a ligroin/
propylene glycol system (2). Appropriate areas
were eluted in accordance with mobilities of pure
crystalline steroid standards. The individual
fractions were then measured by the Zimmerman
reaction.
The total 17-hydroxycorticoids were measured
as Porter-Silber chromogens following butanol
extraction (3), with duplicate determinations
performed in the analysis of each urine.
After the base-line studies had been performed,
either an androgen or an estrogen was adminis-
tered for a period of eight weeks to selected sub-
jects. Five individuals received 100 milligrams of
methyl testosterone orally daily. Sebum pro-
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FIG. 1. Mean sebum output values in castrate
males, arranged by age groups.
duction was measured following androgen ad-
ministration and compared to pre-treatment
values. Since methyl testosterone is not
cataholized to 17-ketosteroids, urine studies were
not carried out in this group.
To eight other subjects, estrogen in the form of
ethynyl estradiol*, 1.0 milligram orally daily, was
administered for eight weeks and sebum secretion
similarly assayed. In addition, in 6 of the 8 sub-
jects receiving estrogen, study of the excretion of
urinary steroids was carried out before and after
its administration.
RESULTS
Seburn Production
The mean values for lipid output in the male
castrates, arranged by age groups, are shown
diagrammatically in Fig. 1. From the age of 30
to 45, the values are relatively constant, but
then begin to decline and after the age of fifty
are markedly reduced. The significance of this
secretion pattern in the castrate will be discussed
later. Analysis of the lipid results within each
age group revealed no correlation between sebum
production and length of time since castration.
The specific mean values for sebum production
with their standard deviations for male castrates
as compared to those for normal males and
females of various ages are listed in Table 1.
In addition, the data are graphically illustrated in
Fig. 2. Included in the "normal" control groups
are values for mentally retarded subjects with
intact gonads. Their inclusion in the control
* Ethynyl estradiol (Estinyl®) supplied by
Roger W. Cooper, M.D., Shering Corporation,
Bloomfield, New Jersey.
groups is valid, since we have found that scbum
secretion in mentally retarded individuals of
different ages is comparable with that of normal
persons.
At all ages studied, sebum production in the
castrate male is significantly lower than that of
the intact male. This disparity is particularly
striking beyond the age of fifty. Here, levels for
intact males remain comparatively high in
contrast to those of aged females in whom sebum
production falls to low levels, as also noted by
previous investigators (4—7). In the female,
sebum production before the age of 50 is sig-
nificantly higher than that of the castrate male
(age 30—40, P < 0.01; age 40—50, 0.05 < P >
0.02). After the age of 50, however, schum
secretion falls abruptly and approximates that
of the castrate male. It is interesting to note that,
while sebum secretion in the intact male is
consistently higher than in the female, it differs
significantly only after the age of 50. Also note-
worthy is the finding that in neither the aged
castrate nor the aged female does the mean value
of scbum (0.64 milligrams and 0.87 milligrams,
respectively) fall to that of the prcpubcral
subject (0.38 milligrams). However, only S
prcpubcrals have been studied to date, and a
valid comparison is therefore not as yet possible.
In this regard, it should be mentioned that the 6
castrate subjects orchicctomizcd prior to puberty
had practically identical schum values as those
of subjects castrated during or after puberty.
Thus, prepuberal castration does not forestall
sehaceous gland development.
Urine Studies
Table 2 details the results of the urinary
excretion of 17-ketosteroids and 17-hydroxy-
corticoids in the fourteen male castrates, age 32
to 49. For comparison, Table 3 lists the results of
similar studies carried out in seven normal intact
males, age 35 to 45. No significant differences
were observed in the urinary excretion of either
the 17-kctosteroids or the 17-hydroxycorticoids.
The only possible exception was a decreased mean
excretion of androsterone in the castrate group
(0.05 < P > 0.02). However, combined an-
drosterone-etiocholanolonc excretion was quite
similar in the two groups, 2.5 milligrams in the
castrates and 2.9 milligrams in the normals, a
difference of only 13.8 per cent. Therefore, even
though androstcronc and ctiocholanolone are the
chief excretory end-products of testosterone, no
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TABLE 1
,Sebum production (mean and standard deviation), expressed as milligrams of lipid per ten square
centimeters per three hours, in intact males, females and castrate males
Age
Intact Males Females Castrate Males
No. Sebum Production No. Sebum Production No. Sebum Production
7—11
20—29
30—39
40—49
>50
8
44
37
15
32
0.38
2.55 1.05
2.45±0.87
1.91 0.97
2.00 1.06
24
14
15
18
2.09 0.88
1.93±0.89
1.84 1.27
0.81 0.13
28
40
17
1.23±0.72
1.15 0.99
0.64 0.36
indicating a uniform rather than a dispropor-
tionate difference in the excretion of these com-
pounds.
FIG. 2. Comparison of mean sebum levels in
prepuberal children, intact males, intact females
and male castrates.
statistically significant diminution in 17-keto-
steroid excretion was observed in the castrate
males.
If, however, as shown in Table 4, the results
of the fourteen castrate urines are arbitrarily
divided into two separate groups, one com-
prising those seven subjects with high sehum
output (mean 2.44, range 1.27—5.27) and the
other those seven subjects with low sebum
output (mean 0.62, range 0.32—1.17), then a
definite correlation is observed between the mean
sebum production and the mean excretion of
both 17-ketosteroids and 17-hydroxycorticoids.
In fact, the urine values of the low sebum group
are in most instances approximately fifty per
cent less than the high sebum group. However,
the relative amount of 17-ketosteroids appearing
in the urine are nearly identical in the two groups,
Effect of Hormone Administration
A. Methyl testosterone. Fig. 3 illustrates the
effect on sebum secretion in the five male castrate
subjects administered 100 milligrams of methyl
testosterone orally for eight weeks. An increase
in sebum production occurred in 4 of the 5
subjects, being quite marked in 2. The one
subject not showing any change in sebum secre-
tion developed jaundice during the sixth week
of methyl testosterone administration, at which
time the drug was discontinued. Thus, glandular
secretion may have actually increased in this
particular case, but could well have returned to
pre-treatment levels by the time sebum measure-
ments were performed.
B. Ethynyl estradiol. The effect on sebum pro-
duction in eight male castrates to the adminis-
tration of 1.0 milligram of ethynyl estradiol
orally daily for eight weeks is shown in Fig. 4.
In every case, sebaceous secretion was un-
equivocally decreased, although the degree of
suppression varied from subject to subject.
In 6 of the 8 subjects receiving estrogen, the
urinary excretion of 17-ketosteroids and 17-
hydroxycorticoids was assayed prior to and at
the end of its administration. The values obtained
for each subject appear in Table 5. While some
variation in response was observed, the mean
values for 17-hydroxycorticoids and the indi-
vidual 17-ketosteroids were practically unchanged
following estrogen administration.
DISCUSSION
The findings in this investigation together with
information obtained from other studies have
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TABLE 2
clarified considerably the role of hormonal
substances in the control of human sebaceous
secretion. The first observation of importance in
this study is that sebum production in the
castrate male is significantly lower at all ages
than that of the intact male. Particularly note-
worthy is the fact that, while the comparatively
low secretion in young to middle-aged castrate
males falls to even lower levels in old age, sebum
secretion in the elderly intact male remains
relatively high. This difference in sebaceous
gland activity between the castrate male and the
intact male is almost certainly due to testicular
androgen, since we know that the sebaceous
glands are highly sensitive to androgen. For
example, small amounts of testosterone, ad-
ministered to prepubéral subjects in whom the
sebaceous glands are normally small and un-
differentiated, result in a marked and rapid
increase in their size and activity (8). However,
when testosterone in very large amounts is
administered to adult intact males, in whom the
Total and fractional urinary 17-/cetosteroids and total urinary
age 32—49
Total 17-hy-
droxycorticoids,
mg/24 hrs
Total 17-keto-
steroids, mgi
24 hrs
Dehydro-
epiandrosterone
17-hydroxycorticoids in castrate males,
Androsterone Etiocholariolone Il-hydroxy-androsterone
ll-ketoetio-
cholanolone
7.8
1.0
10.5
1.4
7.6
1.1
1.4
2.9
1.4
1.4
1.0
2.0
1.0
5.9
5.8
12.4
10.8
3.6
9.1
4.1
3.7
3.6
3.5
3.0
4.8
4.4
5.0
1.0
1.6
1.0
1.7
0.5
1.9
1.2
0.7
0.7
0.7
0.4
0.7
0.7
1.2
1.7
1.1
1.6
2.0
0.5
1.6
0.6
0.9
0.7
0.6
0.2
0.7
0.7
0.7
1.5
0.4
4.2
3.5
1.1
2.9
0.5
0.5
0.8
0.9
0.8
1.6
0.7
1.5
1.0
1.5
3.1
2.1
1.0
1.5
1.1
0.9
0.9
0.6
0.6
0.8
0.9
0.8
0.7
1.2
2.5
1.5
0.5
1.2
0.7
0.7
0.5
0.7
1.0
1.0
1.4
0.8
Mean &
S.D.
3.1 5.7 1.0 1.0 1.5 1.2 1.0
TABLE 3
Total and fractional urinary 17-ketosteroids and total urinary 17- hydroxycorticoids in normal males,
age 35—45
Total 17-hy-
droxycorticoids
mg/24 hrs
Total 17-keto-
steroids, mg/
24 hrs
Dehydr
epiandrosterone Androsterone EtiocholanoloneI
il-hydroxy-
androsterone
ll-ketoetio-
cholanolone
7.3
5.9
1.0
5.9
5.1
3.3
1.5
5.9
9.6
4.3
4.9
5.6
5.2
7.2
2.0
3.9
0.2
0.7
0.2
1.5
2.6
2.3
1.7
1.5
1.3
1.1
1.3
1.6
0.1
2.0
1.4
1.6
2.4
1.1
1.4
0.9
1.2
0.5
0.6
0.9
0.9
1.1
0.6
0.8
0.7
0.7
1.0
0.4
0.5
Mean &
S.D.
4.3 6.1 L6 1.4 0.7
±0.2
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TABLE 4
Comparison of urinary steroid excretion in male
castrates with high sebum output vs. low
sebum output
High
sebuin
group
Low
sebum
group
Sebum production, mg/b sq
cm/3 hrs 2.44 0.62
Total 17-ketosteroids, mg/24
hrs
Dehydroepiandrosterone
Androsterone
Etiocholanolone
il-hydroxyandrosterone. . .
il-ketoetiocholanolone
7.4
1.3
1.3
2.0
1.6
1.2
4.0
0.7
0.6
1.0
0.8
0.9
Total 17-hydroxycorticoids... 4,4 1.6
glands are normally well developed, no response
is observed, suggesting that physiologically
there is more than an adequate amount of
circulating androgen to stimulate the glands
maximally. In this study, the demonstration of
an increase in sebum output in the castrates
following methyl testosterone administration
indicates that the glands normally were not being
maximally stimulated by endogenous androgen.
Furthermore, we have iecently observed that
orchiectorny in the elderly male with prostate
cancer results in a rapid and marked fall in
sebum production, declining to a level similar to
that of the elderly castrate males in the present
study (9). Thus, even in the aged intact male, at
a time when testosterone production ordinarily
wanes and in some instances considerably,
apparently sufficient amounts are secreted to
adequately stimulate the sebaceous glands.
The second major finding was that castration
prior to puberty did not prevent sebaceous gland
development, nor did the sebum level for the
castrate males, including aged subjects, fall to
that of the prepuberal subject. Therefore, there
is of necessity a source, aside from the gonads,
for the post-pubertal stimulation of sebaceous
glands. While it is not absolutely certain what
the source and nature of these compounds are,
indirect evidence leads us to believe that it is
adrenal androgen. The urine studies comparing
male castrates with higher sebum levels to those
with lower sebum levels demonstrated an ab-
FIG. 3. Sebum secretion in five male castrates
before and after administration of 100 milligrams
of methyl testosterone orally daily for eight
weeks. Each bar represents a single subject. The
unshaded areas are the pre-treatment values,
and the shaded areas are the increase in sebum
production in each subject.
FIG. 4. Sebum production in eight male castrates
before and after the administration of 1.0 milli-
gram of ethynyl estradiol orally daily for eight
weeks. Each bar represents a single subject. The
total height of the bars are the pre-treatment
values, and the shaded areas represent the decrease
in sebum secretion in each subject.
solute correlation with 17-ketosteroid excretion.
In the castrate all of these urinary steroids are of
adrenal origin. However, since both the il-oxy-
17-ketosteroids (cortisol metabolites) and the
17-hydroxycorticoids were similarly reduced in
the group with lower levels of sebum production,
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TABLE 5
Effect of estrogen administration on sebum production and urinary steroid excretion in castrate males
Subject Sebum
Total 17-
hydroxy-
corticoids,
mg/24 hrs
Total 17-
keto-
steroids,
mg/24 hrs
Dehydro-
epiandros-
terone
Andros-
terone
Etiochol-
anolone
il-hydroxy-
androsterone
ll-ketoetio-
cholanolone
1 Before
After
2 Before
After
3 Before
After
4 Before
After
5 Before
After
6 Before
After
3.36
0.96
1.50
0.51
1.42
0.40
1.27
0.71
1.17
0.48
1.14
0.71
1.0
1.7
7.6
2.9
1.1
1.0
1.4
4.3
2.9
2.2
1.4
1.7
5.8
5.2
3.6
1.9
9.1
7.6
4.1
4.1
3.7
6.8
3.6
5.2
1.6
1.3
0.5
0.5
1.9
1.4
1.2
0.8
0.7
1.6
0.7
0.6
1.1
0.9
0.5
0.3
1.6
1.4
0.6
0.8
0.9
1.2
0.7
0.8
0.4
0.1
1.1
0.3
2.9
1.8
0.5
1.2
0.5
1.7
0.8
1.6
1.5
2.6
1.0
0.4
1.5
1.9
1.1
0.6
0.9
1.6
0.9
1.2
1.2
0.3
0.5
0.4
1.2
1.1
0.7
0.7
0.5
1.0
0.8
0.7
MeanBefore
After
2.6
2.3
5.0
5.1
1.1
1.0
0.9
0.9
1.1
1.1
1.1
1.4
0.8
0.7
it is not possible to relate decreased sebum
production absolutely and solely to decreased
adrenal androgen production (1 1-desoxy-17-
ketosteroids). And, although as noted previously,
the sebaceous glands are highly sensitive to
androgens, it will be necessary to show that these
adrenal androgens are in fact capable of stimu-
lating human sebaceous glands, before assigning
to them a physiologic role for such activity. It
should also be noted that the fall in sebaceous
secretion in the elderly castrate parallels the
decrease in adrenal androgen production known
to occur with advancing age, the excretion of
11-oxy-17-ketosteroids undergoing very little
diminution (10). Thus, again it seems more
reasonable to infer that the adrenal androgens
rather than the corticoids are the source for
sebaceous gland stimulation.
In the female, the nature of the normal stimulus
for sebaceous secretion is not quite as apparent
as it is in the male. The mean sebum output
before the age of 50 in females is somewhat
lower than in the intact male, but it is sig-
nificantly higher than that of the castrate male,
especially between the age of 30 and 40 (P <
0.01). In this connection, our findings differ
from those of Emanuel who reported sebum
levels in eight castrate males, age 30 to 40, to be
similar to those of 20 females of the same age
(11). After the age of fifty, we found that sebum
production in the female falls to levels similar
to those of male castrates. Therefore, it is plainly
evident that prior to the age of 50, the female
receives an added impetus to sebum secretion
over that of the castrate male. Theoretically,
this could be due to increased adrenal androgen
production in the female, but since this does not
occur normally (12), this possibility is excluded.
It is necessary, therefore, to postulate the
presence of an extra-adrenal source for the
stimulation of sebaceous glands in the female.
The ovary must receive serious consideration as
a possible source of such substances, since sebum
secretion falls abruptly after the age of 50 when
the ovary undergoes involution. Progesterone
from the ovary has often been considered to be
of importance in controlling sebaceous gland
activity. However, the studies of Strauss and
Kligman in the human (13) and of Ebling in the
rat (14) have demonstrated conclusively that
physiologic amounts of progesterone do not
cause sebaceous gland hyperactivity.
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Evidence points toward an androgen as the
responsible agent. Androgenic compounds, such
as androst-4-ene-3 , 17-dione, have been isolated
from normal ovaries (15), but it remains to be
seen whether such compounds affect sebaceous
glands, and, if so, whether they are secreted in
amounts sufficient to stimulate them. Of con-
siderable interest are the findings of Dorfman
that testosterone is present in the blood plasma
of normal females and in a concentration approxi-
mately one-fourth that of the intact male (16).
While testosterone has not been isolated from
normal ovaries, incubation experiments with
radioactive precursors have demonstrated its
formation in vitro by normal human ovarian
tissue (17).
The results of the urinary excretion of the
17-ketosteroids and the 17-hydroxycorticoids in
the castrate male and their comparison with the
intact male are of considerable importance and
deserve special comment. The excretion of total
17-ketosteroids, dehydroepiandrosterone and an-
drosterone were somewhat lower in the castrates
as compared to the normals. However, it was not
possible to detect any significant differences
between the two groups. These findings are not
completely without precedence, however. Two
previous workers, in investigations involving
many of the same castrate subjects used in this
study, found no significant differences in the
24-hour excretion of total 17-ketosteroids (18, 19)
or of total 17-hydroxycorticoids (19). This failure
to detect a statistically significant diminution in
total or individual 17-ketosteroid excretion in
the castrate male is consistent with the observa-
tions of VandeWiele and Lieberman, who de-
termined by in vivo radioactive experiments in
human subjects that most of the urinary an-
drosterone and etiocholanolone is derived from
dehydroepiandrosterone (20). They have esti-
mated that the endogenous production of de-
hydroepiandrosterone in the adult male to be
approximately 25 milligrams per day, while
that of testicular androgen to be between 2.5 and
4.5 milligrams per day (21). On the basis of these
observations, it is obvious that while testosterone
is potent biologically, it is not produced in a
sufficient quantity to contribute appreciably to
the urinary 17-ketosteroids. If the observations
concerning the endogenous production of dehy-
droepiandrosterone and of testicular androgen
are correct—and our urine studies in the castrates
lend considerable support to them—their im-
portance cannot be overemphasized in the con-
sideration of androgen-sensitive organs, such as
the sebaceous glands. For example, relatively
small differences in testosterone production might
materially affect the activity of the glands, but
not be detected by significant alterations in 17-
ketosteroid excretion.
It should not pass unnoticed that our results
of the urine excretion of individual 17-keto-
steroids in castrates are not in accord with those
reported by Johnsen (22). He found a significant
decrease in the mean excretion of dehydro-
epiandrosterone, androsterone and etiochol-
anolone, as compared to normal intact males.
The difference in androsterone-etiocholanolone
excretion in his two groups was very high (68
per cent), as compared to a difference of only 14
per cent in our study. This discrepancy in andros-
terone-etiocholanolone excretion may be partly
explained, at least, by his finding reduced ex-
cretion of 1l-oxy-17-ketosteroids in the cas-
trates, suggesting to us that they may have
been relatively hypoadrenal to the normal
control group. As such, a reduction in the forma-
tion of 11-desoxy-17-ketosteroid precursors was
to be expected.
The suppression of sebum secretion in the
castrate by estrogen is difficult to explain. In
studies reported elsewhere (8), we have shown
that comparable doses of ethynyl estradiol
result in similar suppression in both females and
intact males. Furthermore, we concluded that
the effect did not appear to be the result of
direct sebaceous gland suppression, but rather
the result of a central inhibition mechanism. For
example, in the male and possibly even in the
female, part or all of this suppression could
result from inhibition of goriadotropins by
estrogen, but this certainly does not explain the
mechanism of action in the castrate. Suppression
of adrenal androgen production is an enticing
possibility, despite the fact that there is no
evidence in the human that estrogens inhibit
adrenocortical activity directly or indirectly
(23—25). However, our results showing no altera-
tions in 17-ketosteroid or 17-hydroxycorticoid
excretion in the castrates following estrogen
administration have rendered this possibility
rather unlikely.
Thus, the action of estrogen on the sehaceous
gland is not at all clear at this point. It should
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perhaps be stressed that the dose of estrogen
necessary to suppress sebaceous secretion, as
detected by our assay method, is ordinarily
pharmacologic rather than physiologic, and its
potential effects on any number of organs in the
body must be kept in mind. One possible mech-
anism of action is inhibition of a pituitary
hormone, such as sebotrophin (26), which is
neither an adrenocorticotrophin nor a gonado-
trophin. It must be emphasized, however, that
sebotrophin has not been demonstrated in man,
and, as such, speculations concerning it should
be entertained with considerable caution.
SUMMARY
1. Sebum production has been determined in
85 surgically castrate males by a quantitative
gravimetric technic. Sebum production in the
castrate is relatively constant up to the age of 50,
but declines to much lower levels in older cas-
trates. Sebum secretion in the castrate is sig-
nificantly lower in all age groups when compared
to intact males, and significantly lower in sub-
jects under 50 years old when compared to
females. In those subjects castrated before pu-
berty, sebum output is higher than the pre-
puberal seburn level; even in the elderly castrates,
sebum production exceeds the prepuberal levels.
2. There is no significant difference in the 24-
hour urinary excretion of total 17-hydroxycorti-
coids or of total and fractional 17-ketosteroids
in castrate males and intact males. However,
within the castrate group, those subjects with
higher sebum levels have a higher urinary 17-
ketosteroid and 17-hydroxycorticoid excretion
when compared to subjects with low sebum
production.
3. The oral administration of 100 milligrams
of methyl testosterone daily for eight weeks
resulted in an increased sebum output in 4 of 5
castrate males.
4. The oral administration of one milligram
of ethynyl estradiol daily for eight weeks re-
sulted in a decreased secretion in all 8 castrate
males studied. However, there was no alteration
in the urinary steroid excretion pattern following
estrogen treatment.
5. We have concluded that the major stimulus
for sebum secretion in the intact male is testicular
androgen, while in the castrate male it is adrenal
androgen. In the female, adrenal androgen also
is probably the stimulus for sebaceous gland
development, but in the premenopausal female
an additional source of androgens, probably
ovarian, also contributes to glandular develop-
ment.
6. The urinary steroid excretion data, in
confirmation of the results of most workers,
indicate that testicular androgen is of minor
importance in its contribution to urinary 17-
ketosteroids.
7. There is no evidence to indicate that the
sebum-suppressive action of ethynyl estradiol in
the castrates is mediated by suppression of
adrenal androgens as measured by the urinary
excretion of the 17-ketosteroids.
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DISCUSSION
DR. ALLAN L. LORINCZ, Chicago, Ill.: As we do not know, at this point, the mechanism of
regards the effect of estrogen noted in these sebum suppression in male castrates by estrogen.
interesting studies on castrated individuals, I There are several possibilities, such as direct
wonder whether Dr. Pochi believes this could be sebaceous gland suppression, inhibition of sebo-
mediated through suppression of some pituitary
sebotropic principle or does he prefer some other
explanation for this phenomenon.
DR. PETER E. PocHI, (in closing): Dr. LorincZ,
tropin or of adrenal testosterone production.
However, there is no evidence, as yet, that any
of these mechanisms are operative.
